Charles A. Reinhart, III
2017
In 2017, Charles A. Reinhart, III earned a total compensation of $1.3M as Chief Financial Officer at Pacira Pharmaceuticals, a 45% decrease compared to previous year.
Compensation breakdown
| Bonus | $147,240 |
|---|---|
| Option Awards | $360,121 |
| Salary | $408,654 |
| Stock Awards | $386,750 |
| Other | $16,170 |
| Total | $1,318,935 |
Reinhart received $408.7K in salary, accounting for 31% of the total pay in 2017.
Reinhart also received $147.2K in bonus, $360.1K in option awards, $386.8K in stock awards and $16.2K in other compensation.
Rankings
In 2017, Charles A. Reinhart, III's compensation ranked 7,648th out of 14,666 executives tracked by ExecPay. In other words, Reinhart earned more than 47.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,648 out of 14,666 | 48th |
Division Manufacturing | 2,864 out of 5,772 | 50th |
Major group Chemicals And Allied Products | 928 out of 2,075 | 55th |
Industry group Drugs | 720 out of 1,731 | 58th |
Industry Pharmaceutical Preparations | 561 out of 1,333 | 58th |
Source: SEC filing on April 27, 2018.
Reinhart's colleagues
We found four more compensation records of executives who worked with Charles A. Reinhart, III at Pacira Pharmaceuticals in 2017.